IgA Nephropathy (IgAN)

Autoimmune Protocol Diet Intervention on Proteinuria in IgA Nephropathy Patients

Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease

RESistance of IgA Nephropathy to Conventional and Newly-approved Therapies: an Observational, Real-life Study (RESIGAN)

A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept

Mediators of Loin Pain in IgA Nephropathy

A Study to Evaluate the Long-Term Safety and Efficacy of HSK39297 Tablets in Primary IgA Nephropathy

Exploring the Brain - Gut Microbiota - Kidney Interactive Damage Mechanisms Underlying Cognitive Decline in Patients With IgA Nephropathy Using Ultra-high Field Magnetic Resonance Imaging

Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of EVER001 in Participants With Selected Proteinuric Glomerular Diseases

Phase II Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN

Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN

Efficacy and Safety of Nefecon on Prevention of Relapse of IgA Nephropathy: a Randomized, Double-blinded, Placebo-Controlled Trial

CD19/BCMA UCAR-T for B Cell-Related Autoimmune Disease

Clinical Experience With Sparsentan in Switzerland in IgA Nephropathy

SLN12140 in Adult Participants With IgA Nephropathy in China

A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in the Treatment of Immune-mediated Kidney Diseases

Efficacy and Safety of CD19 CAR-γδ T Cells in the Treatment of Relapsed/Refractory Autoimmune Nephropathy

Monthly Dosing of Atacicept in IgAN

Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease

A Study of RG002C0106 Injection in Adult Participants With Normal Renal Function and Mild-to-Moderate Renal Impairment

CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease